A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Clinical trial NCT01195662 · COMPLETED
Trial details
- NCT number
- NCT01195662
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2013-02-01
- Enrollment
- 2245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.